In recent years, the management of Attention-Deficit/Hyperactivity Disorder (ADH...
In a groundbreaking study published in Cell Death Discovery, researchers have un...
In a groundbreaking advance in the battle against Parkinson’s disease, researche...
In a groundbreaking new study published in npj Parkinson’s Disease, researchers ...
In a recent rigorous cohort study published in JAMA Health Forum, researchers ha...
In a groundbreaking advancement that could revolutionize wearable health technol...
The European Commission (EC) has granted marketing authorisation to Sydnexis for...
Regeneron and Sanofi’s blockbuster Dupixent has transformed the atopic dermatiti...
Vividion Therapeutics has secured worldwide rights for developing and commercial...
The alert comes amid some patients accessing GLP-1RAs through unregulated channe...
China’s NMPA has approved Akeso's PD-1/CTLA-4 bispecific antibody, cadonilimab, ...
SCHOTT Pharma has announced an investment of €100m ($114m) to expand its manufac...
During an FDA panel discussion, the US health secretary prioritised easier route...
A study found no rise in ADHD cases, though some drugs for the disorder are stil...
Juvenescence has acquired Ro5 to enhance its AI/machine learning capabilities an...
In a groundbreaking study published in Pediatric Research in 2025, researchers N...
